Today: 9 April 2026
DroneShield stock to watch after JPMorgan crosses 5% line; ASX:DRO ends week above A$4
10 January 2026
2 mins read

DroneShield stock to watch after JPMorgan crosses 5% line; ASX:DRO ends week above A$4

Sydney, Jan 10, 2026, 17:48 AEDT — Market closed

  • JPMorgan Chase & Co. disclosed a 5.09% holding in DroneShield in a Jan. 9 filing
  • DroneShield shares last closed up 4.4% at A$4.02; ASX reopens Monday
  • Focus turns to Q1 deliveries and cash receipts, ahead of February audited results

DroneShield Limited shares head into Monday’s trade in focus after a filing showed JPMorgan Chase & Co. and its affiliates had become a substantial holder in the Australian counter-drone systems maker. The U.S. bank group reported voting power of 5.09%, or about 46.5 million ordinary shares, after crossing the 5% threshold on Jan. 7, the notice dated Jan. 9 showed.

The disclosure lands as DroneShield tries to rebuild trust after a late-2025 slide tied to executive share sales and governance questions. “Investors have lost confidence in the stock after the directors, including the CEO and the chairman, sold every single share,” said Ron Shamgar, head of Australian equities at TAMIM Asset Management, in a November Reuters report.

DroneShield last closed up 4.4% at A$4.02 on Friday. Yahoo Finance

The filing came after the close, so it will be digested when the ASX reopens on Monday. Big bank names on a small-cap register can shift sentiment quickly, even when it’s not a straight “buy and hold” trade.

Australian rules require disclosure once an investor’s voting power tops 5%, and again when it moves by 1% or more. JPMorgan’s notice splits the holding across its trading, prime brokerage and stock-lending operations. A chunk of the position sits inside lending arrangements — shares temporarily loaned out and later returned — which can make stakes move around without a fresh view on the company’s outlook.

DroneShield has tried to pull attention back to orders, deliveries and cash. On Dec. 30 it said it had received an A$8.2 million order for a western military end-customer, with delivery expected by end-2025 or early Q1 2026 and payment expected in Q1; it also flagged about A$97.7 million in “locked in revenues” going into 2026.

Earlier in December, the company said it had received a A$49.6 million contract from a European reseller for a military end-customer, with deliveries and cash payments expected to be completed in Q1 2026.

Investors are now waiting for audited numbers and a cleaner read on cash conversion; in a December investor deck, DroneShield said its audited 2025 results are due in February as part of the annual report. Traders are likely to focus on cash receipts, margins and whether the late-2025 contract burst turns into cash on time in the March quarter.

But a “substantial holder” notice can reflect stock-lending and prime-brokerage flow as much as conviction, and positions can unwind fast if clients return borrowed stock. Any slip in delivery schedules or slower cash collection would test a stock that has shown it can move hard in both directions.

When the ASX reopens on Monday, Jan. 12, attention will be on whether DroneShield can hold the A$4 level and whether further 5% notices follow. After that, the next marker is the company’s February annual report and audited results.

Stock Market Today

  • Guard Therapeutics Faces Potential Delisting from Nasdaq First North Growth Market
    April 9, 2026, 12:06 PM EDT. Guard Therapeutics International AB has been notified by Nasdaq that it currently fails to meet the active operations requirement, risking delisting by June 17, 2026. The company is exploring a merger or reverse acquisition to satisfy Nasdaq's operational criteria. A transaction structure is expected to be proposed in Q2 2024, allowing Nasdaq to reassess the listing status. If no agreement is reached, the board will recommend voluntary delisting and liquidation, returning available funds to shareholders. Final decisions will be taken by shareholders at a general meeting. Guard Therapeutics focuses on developing therapies for kidney diseases based on the alpha-1-microglobulin protein and is listed under the ticker GUARD.

Latest article

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

9 April 2026
Palantir Technologies dropped about 7% Thursday after Michael Burry said Anthropic was overtaking it in enterprise AI, putting Palantir on track to lose $34 billion in market value. Anthropic reported its annualized revenue run rate had surged past $30 billion and launched new AI tools for businesses. Nearly one in four businesses on Ramp now pays for Anthropic, according to Ramp data. Palantir’s stock still trades at 395 times earnings.
Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

9 April 2026
Salesforce shares hit a new 52-week low Thursday, dropping 3.7% to $169.76 despite reporting 12% revenue growth and strong demand for its AI products. The broader software sector continued to slide, with the S&P 500 software and services index down about $1 trillion since January. Salesforce raised its buyback authorization to $50 billion and increased its dividend to 44 cents a share.
ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

9 April 2026
ServiceNow shares dropped 5.1% to $92.45 by 10:20 a.m. EDT Thursday, hitting a new 52-week low after analysts at Stifel, BTIG, and Goldman Sachs cut price targets citing weak federal spending and limited 2026 growth. The company announced it will integrate AI, data, security, and governance into all products ahead of first-quarter results due April 22.
SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

9 April 2026
SoFi Technologies shares fell 1.9% to $16.18 Thursday after KBW and Wells Fargo cut price targets ahead of first-quarter results due April 29. The moves follow Muddy Waters’ short position and claims of accounting issues, which SoFi denies. Affirm and LendingClub also traded lower. Barclays and other banks have trimmed targets as concerns mount over credit quality and sector valuations.
Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

9 April 2026
Tesla is developing a smaller, cheaper electric SUV to be built first in Shanghai, sources said. The new model would cost less than the Model 3 and be smaller than the Model Y. Tesla produced 408,386 vehicles but delivered only 358,023 in Q1, as U.S. demand weakened and competition increased. Shares fell 0.8% Thursday.
Mineral Resources stock rises after director share filings as Jan 29 update nears
Previous Story

Mineral Resources stock rises after director share filings as Jan 29 update nears

DBS stock in focus after ‘risk transfer’ report: key levels and dates to watch
Next Story

DBS stock in focus after ‘risk transfer’ report: key levels and dates to watch

Go toTop